previous
describ
use
doubl
coat
agaroseagaros
porcin
islet
macrobead
treatment
type
diabet
mellitu
current
studi
longterm
viral
safeti
macrobead
implant
pancreatectom
diabet
dog
treat
pravastatin
assess
dog
serv
nonimpl
control
gradual
return
preimplant
insulin
requir
occur
implant
procedur
day
compar
first
macrobead
implant
day
macrobead
implant
anim
three
implant
dog
porcin
cpeptid
detect
blood
least
day
follow
first
implant
least
day
follow
second
implant
cpeptid
also
present
periton
fluid
three
implant
dog
month
implant
dog
necropsi
prescreen
result
islet
macrobead
cultur
media
prior
transplant
neg
virus
evid
perv
viral
transmiss
found
throughout
studi
studi
demonstr
longterm
year
implant
agaroseagaros
encapsul
porcin
islet
safe
procedur
larg
anim
model
type
diabet
mellitu
patient
alreadi
receiv
immunosuppress
therapi
kidney
allograft
altern
insulinproduc
islet
isol
major
pancrea
transplant
alon
free
islet
note
necessari
compon
transplant
allogen
pancrea
islet
alon
need
lifelong
immunosuppress
therapi
complic
immunosuppress
therapi
includ
increas
suscept
infect
malign
neurotox
nephrotox
allotransplant
must
care
consid
often
suitabl
young
patient
avail
human
donor
pancrea
extrem
limit
pancrea
donor
per
year
wors
type
diabet
insulinproduc
islet
langerhan
scatter
throughout
pancrea
select
destroy
appar
autoimmun
process
daili
often
multipl
inject
exogen
human
recombin
insulin
current
standard
care
despit
continu
advanc
insulin
therapi
fact
patient
surviv
year
insulin
therapi
qualiti
life
difficult
owe
nonphysiolog
deliveri
insulin
bolu
transplant
entir
human
pancrea
deceas
organ
donor
provid
anoth
therapeut
option
diabet
patient
especi
journal
diabet
research
procur
pancreas
meet
criteria
transplant
less
use
islet
isol
overcom
major
hurdl
organ
avail
immunosuppress
report
abil
porcin
islet
encapsul
agaroseagaros
macrobead
restor
normoglycemia
diabet
anim
model
use
pig
islet
sourc
provid
unlimit
number
organ
islet
isol
encapsul
porcin
insulin
nearli
ident
human
insulin
differ
singl
amino
acid
use
clinic
sinc
discoveri
doubl
layer
agaros
encapsul
porcin
islet
also
provid
least
protect
recipi
immun
respons
xenogen
islet
like
amelior
need
immunosuppress
therapi
fact
previous
shown
porcin
islet
macrobead
enabl
discontinu
exogen
insulin
month
studi
termin
spontan
diabet
bb
rat
without
immunosuppress
therapi
current
studi
initi
investig
effect
multipl
implant
encapsul
porcin
islet
pancreatectom
diabet
dog
dog
receiv
islet
macrobead
dog
receiv
exogen
insulin
human
diabet
patient
implant
macrobead
would
chronic
expos
porcin
islet
set
assess
viral
safeti
macrobead
implant
also
screen
variou
canin
tissu
evid
viral
transmiss
year
porcin
islet
macrobead
exposur
total
six
male
devoc
beagl
dog
ridgelan
farm
inc
mount
horeb
wi
receiv
approxim
week
age
dog
individu
hous
stainless
steel
cage
w
l
h
rubberco
mesh
floor
stainless
steel
platform
scienc
diet
growth
hill
provid
twice
daili
clean
municip
water
provid
ad
libitum
viokas
henri
schein
powder
ad
food
dose
tspmeal
follow
pancreatectomi
room
temperatur
maintain
c
rel
humid
light
cycl
maintain
throughout
studi
light
hour
studi
protocol
procedur
approv
rogosin
institut
anim
care
use
committe
iacuc
rogosin
institutexenia
divis
anim
facil
hold
full
accredit
statu
award
associ
assess
accredit
laboratori
anim
care
intern
aaalac
int
macrobead
donor
islet
prepar
newsham
sow
two
year
age
multipl
pariti
electr
stun
exsanguin
bob
evan
farm
xenia
oh
pancreata
retriev
transport
islet
isol
laboratori
cold
hank
balanc
salt
solut
hbss
mediatech
ice
warm
ischemia
time
averag
minut
cold
ischemia
time
rang
minut
one
hour
islet
isol
carri
previous
describ
briefli
trim
gland
fat
connect
tissu
main
pancreat
duct
cannul
inject
hbss
contain
gl
collagenas
p
roch
gl
dnase
sigma
aldrich
twice
gram
weight
pancrea
ml
perfus
pancreat
duct
rate
mlmin
c
islet
purifi
discontinu
eurocollin
mediatech
inc
ficol
sigma
aldrich
gradient
densiti
gcm
gcm
gcm
ml
polystyren
conic
tube
tube
centrifug
rpm
isletcontain
layer
manual
collect
islet
equival
encapsul
agaroseagaros
macrobead
previous
describ
islet
macrobead
maintain
rpmi
contain
porcin
serum
mediatech
antibioticantimycot
aa
gibco
life
technolog
atmospher
co
air
c
macrobead
examin
uniform
collect
day
prior
implant
aliquot
ml
conic
tube
maximum
macrobead
per
tube
store
overnight
room
temperatur
c
rpmi
gibco
life
technolog
contain
aa
screen
prior
islet
macrobead
implant
repres
sampl
macrobead
cultur
media
sent
microtest
laboratori
inc
agawam
product
bioburden
test
ansiaamiiso
part
see
tabl
macrobead
asept
crush
extract
fluid
emd
millipor
cultur
media
test
suppli
use
usp
membran
filtrat
sampl
filter
onto
membran
emd
millipor
hvlp
transfer
tryptic
soy
agar
tsa
plate
cultur
c
c
day
aerob
anaerob
aerob
spore
former
addit
sampl
filter
onto
membran
transfer
sabouraud
dextros
agar
sda
plate
incub
c
c
day
yeast
mold
usp
microbi
limit
test
salmonella
sp
also
perform
incub
sampl
lactos
broth
hour
c
aliquot
mltube
sctt
tube
follow
addit
hour
c
c
upon
complet
incub
content
streak
brilliant
green
agar
bga
xylos
lysin
desoxychol
xld
agar
bismuth
sulfit
bs
agar
plate
hour
c
c
bioburden
test
includ
neg
media
control
appropri
posit
media
control
escherichia
coli
atcc
aerob
clostridium
sporogen
atcc
anaerob
bacillu
subtili
atcc
aerob
sporeform
candida
albican
atcc
yeast
mold
coloni
count
use
reichert
quebec
darkfield
coloni
counter
class
organ
total
recover
bioburden
cfusip
calcul
cultur
media
sip
ml
per
categori
macrobead
sip
bead
cultur
media
islet
macrobead
also
sent
iowa
state
univers
veterinari
diagnost
laboratori
vdl
ame
ia
addit
microbiolog
porcin
lymphotrop
herp
viru
pcr
swine
hemagglutin
encephalomyel
viru
shev
rtpcr
porcin
parvoviru
ppv
pcr
porcin
cytomegaloviru
pcmv
pcr
mycoplasma
hyopneumonia
pcr
pseudorabi
viru
prv
viru
isol
encephalomyocard
viru
emcv
viru
isol
group
rotaviru
antigen
captur
elisa
chlamydia
spp
antigen
captur
elisa
rtpcrpcr
assay
includ
posit
control
templat
control
perform
accord
standard
oper
procedur
vdl
time
surgic
procedur
second
macrobead
implant
day
implant
sham
surgeri
nonimpl
control
white
blood
cell
biopsi
mesenter
lymph
node
tonsil
collect
studi
anim
immedi
snapfrozen
sampl
ship
dryic
bioreli
glasgow
scotland
assess
perv
quantit
realtim
pcr
qrtpcr
appropri
control
includ
posit
control
neg
control
nucleic
acid
spike
viral
target
sequenc
postextract
spike
control
assess
target
specif
pcr
inhibit
exogen
intern
posit
control
establish
neg
pcr
result
truli
neg
due
fail
amplif
notempl
control
monitor
aerosol
reagent
contamin
neg
control
monitor
reagent
contamin
sentinel
extract
control
assess
possibl
airborn
sampl
sampl
crosscontamin
conduct
triplic
assay
necropsi
sampl
retriev
islet
macrobead
swab
periton
caviti
sent
steril
test
per
usp
via
membran
filtrat
product
immers
microtest
laboratori
inc
use
direct
cultiv
cell
cultur
method
retriev
islet
macrobead
screen
presenc
mycoplasma
microtest
laboratori
inc
per
fda
pointstoconsid
character
cell
line
use
produc
biolog
macrobead
also
screen
presenc
bacteri
endotoxin
microtest
laboratori
inc
follow
procedur
depict
fda
guidanc
bacteri
endotoxin
test
sampl
retriev
macrobead
white
blood
cell
bone
marrow
mesenter
lymph
node
small
intestin
liver
kidney
heart
lung
central
nervou
system
brain
collect
asept
snapfrozen
sent
bioreli
viral
screen
six
differ
virus
screen
necropsi
tissu
shown
tabl
viru
select
base
ubiquit
natur
swine
semcv
plhv
shepe
pcv
pcmv
perv
specif
presenc
sourc
anim
pcv
perv
transspeci
infect
potenti
semcv
plhv
shepe
pcmv
perv
clinic
signific
sampl
assess
qrtpcr
presenc
specif
porcin
nucleic
acid
sequenc
control
dog
islet
macrobead
implant
dog
probe
sequenc
use
viral
screen
process
proprietari
avail
upon
specif
request
test
conduct
accord
principl
good
laboratori
practic
regul
describ
unit
state
feder
regist
cfr
part
anim
sedat
acepromazin
dose
mgkg
im
henri
schein
anesthet
ketamin
dose
mgkg
fort
dodg
anim
health
diazepam
dose
mgkg
butler
isofluran
ga
henri
schein
surgeri
anim
receiv
buprenorphin
butler
dose
mgkg
im
surgeri
everi
hour
surgeri
continu
day
cefotaxim
claforan
antibiot
henri
schein
dose
mgkg
iv
hour
surgeri
implant
abdomin
subcutan
cutan
incis
close
vicryl
ethicon
vicryl
nylon
ethicon
sutur
mm
mm
precis
skin
stapl
health
care
respect
pancreatectomi
abdomin
subcutan
cutan
incis
close
vicryl
ethicon
polymend
veterinari
product
laboratori
nylon
ethicon
sutur
respect
fourteen
week
follow
arriv
anim
underw
pancreatectomi
induct
insulindepend
diabet
pancrea
expos
periton
midlin
incis
remov
blunt
dissect
follow
induct
anim
maintain
humulin
insulin
eli
lilli
dose
attempt
morn
hr
even
hr
normoglycemia
time
pancreatectomi
major
omentum
also
remov
day
pancreatectomi
three
anim
receiv
implant
porcin
islet
macrobead
dose
equival
daili
insulin
requir
three
dog
receiv
first
implant
underw
second
implant
dose
islet
macrobead
day
implant
insulin
requir
recipi
correspond
number
porcin
islet
macrobead
receiv
given
tabl
time
second
implant
nonimpl
control
anim
receiv
sham
surgeri
anim
receiv
porcin
islet
macrobead
start
pravastatin
mgday
teva
pharmaceut
hr
prior
implant
continu
daili
throughout
cours
studi
vivo
environ
dog
abdomen
would
like
impair
insulin
product
implant
macrobead
compar
care
control
vitro
cultur
environ
opt
implant
dog
enough
macrobead
provid
time
dose
implant
dose
implant
amount
dog
daili
exogen
insulin
requir
insulin
product
hr
period
vitro
cultur
determin
week
prior
macrobead
implant
batch
islet
macrobead
see
averag
quantiti
insulin
secret
per
macrobead
four
week
prior
implant
could
calcul
see
tabl
daili
exogen
insulin
requir
macrobead
implant
dog
multipli
first
implant
second
implant
enough
macrobead
implant
provid
either
dose
insulin
insulin
product
vari
everi
batch
islet
macrobead
prepar
islet
macrobead
evenli
divid
amongst
differ
recipi
dog
anim
receiv
proport
batch
macrobead
base
exogen
insulin
requir
first
implant
dog
receiv
porcin
islet
macrobead
total
macrobead
weight
kg
second
macrobead
implant
dog
receiv
porcin
islet
macrobead
weigh
kg
averag
macrobead
age
time
isol
encapsul
week
dog
time
first
implant
week
second
implant
periton
midlin
incis
made
site
pancreatectomi
examin
presenc
residu
pancreat
tissu
prior
place
macrobead
periton
caviti
immedi
prior
implant
macrobead
wash
three
time
rpmi
contain
aa
gentli
place
periton
caviti
use
steril
plastic
spoon
need
anim
manual
fed
hill
prescript
diet
ad
hill
can
scienc
diet
growth
andor
nutric
evsco
pharmaceut
maintain
normoglycemia
first
hour
implant
individu
anim
medic
observ
record
daili
throughout
studi
observ
includ
appetit
bowel
movement
bodi
weight
blood
glucos
accuchek
simplic
bg
monitor
chemstrip
maximum
valu
mgdl
roch
diagnost
urin
glucos
insulin
therapi
intraperiton
fluid
collect
glucosearginin
challeng
procedur
sampl
test
presenc
porcin
cpeptid
follow
follow
light
anesthesia
iv
cathet
insert
periton
caviti
mlkg
mm
glucos
mm
arginin
solut
inject
infus
procedur
carri
two
implant
dog
receiv
glucosearginin
challeng
though
intraperiton
fluid
collect
initi
minut
timepoint
follow
challeng
standard
radioimmunoassay
linco
research
inc
use
detect
porcin
insulin
k
sensit
uml
porcin
cpeptid
k
sensit
ngml
assay
run
accord
manufactur
instruct
sampl
duplic
refer
standard
control
triplic
complet
necropsi
perform
day
implant
porcin
islet
macrobead
follow
anesthesia
collect
blood
exsanguin
macrobead
randomli
retriev
virolog
snap
frozen
macrobeadstub
histopatholog
fix
neutral
buffer
formalin
nbf
macrobeadstub
microbiolog
snap
frozen
macrobeadstub
macroscop
observ
note
major
organ
system
tissu
photograph
weight
major
organ
record
tissu
sampl
includ
porcin
islet
macrobead
sent
bioreli
viral
screen
sent
patholog
associ
intern
pai
charl
river
compani
west
chester
oh
histopatholog
time
pancreatectomi
pancrea
omentum
fix
nbf
hr
wash
store
ethanol
necropsi
follow
tissu
collect
fix
sent
pai
heart
spleen
liver
kidney
brain
test
duodenum
jejunum
ileum
mesenteri
adren
gland
stomach
lung
diaphragm
abdomin
musculatur
bone
sternum
spinal
cord
sciatic
nerv
epididymu
eye
submandibular
lymph
node
bladder
muscl
thigh
thymu
thyroid
parotid
salivari
gland
tissu
embed
paraffin
section
stain
haematoxylin
eosin
h
e
sampl
analyz
diplomat
american
colleg
veterinari
patholog
macroscop
histopatholog
find
document
histopatholog
perform
accord
standard
oper
procedur
pai
cultur
media
macrobead
sampl
found
neg
bacteri
growth
salmonella
sp
throughout
observ
period
prior
first
macrobead
implant
macrobead
prepar
sampl
correspond
cultur
media
screen
panel
porcin
virus
microbi
agent
describ
shown
tabl
macrobead
media
sampl
test
posit
rtpcr
perv
macrobead
media
sampl
neg
screen
virus
prior
second
macrobead
implant
randomli
select
macrobead
prepar
sampl
correspond
cultur
media
screen
panel
porcin
virus
microbi
agent
first
implant
macrobead
macrobead
media
sampl
posit
perv
neg
screen
agent
follow
pancreatectomi
insulin
requir
adjust
dog
period
dog
consid
exogen
insulin
requir
establish
week
induct
mean
daili
insulin
requir
week
rang
iu
per
dog
figur
three
implant
dog
remain
insulinfre
day
first
implant
islet
macrobead
time
anim
start
unit
insulin
morn
unit
even
respons
rise
blood
glucos
level
figur
b
exogen
insulin
gradual
increas
next
week
blood
glucos
level
stabil
preimplant
insulin
requir
reestablish
week
follow
transplant
control
dog
undergo
macrobead
implant
sham
surgeri
time
first
implant
follow
second
islet
macrobead
implant
three
implant
dog
began
exogen
insulin
therapi
day
presecond
implant
insulin
requir
reestablish
dog
implant
day
day
day
implant
porcin
cpeptid
random
nonfast
porcin
cpeptid
detect
serum
studi
anim
pancreatectomi
prior
macrobead
implant
two
control
dog
throughout
studi
serum
porcin
cpeptid
howev
detect
three
macrobead
implant
dog
transplant
figur
show
minim
level
cpeptid
follow
implant
procedur
level
rang
ngml
cpeptid
level
ngml
ngml
found
day
follow
first
implant
day
follow
implant
cpeptid
level
ngml
ngml
found
day
post
implant
evid
circul
porcin
cpeptid
ngml
porcin
cpeptid
detect
periton
fluid
three
implant
dog
approxim
month
prior
necropsi
intraperiton
glucosearginin
challeng
procedur
figur
b
serum
cpeptid
detect
time
three
implant
dog
control
anim
undergo
periton
challeng
fluid
collect
procedur
necropsi
porcin
cpeptid
detect
periton
fluid
ngml
ngml
resp
periton
fluid
anim
lost
bodi
weight
immedi
pancreatectomi
next
sever
month
studi
anim
regain
weight
surpass
preinduct
level
slight
increas
bodi
weight
also
observ
immedi
period
follow
macrobead
implant
result
macrobead
weight
fluid
therapi
associ
surgic
procedur
complet
necropsi
perform
studi
anim
day
macrobead
implant
explor
periton
caviti
note
major
macrobead
freefloat
intact
macrobead
occasion
found
either
entangl
residu
omentum
tissu
contain
within
pelvic
omentumlik
tissu
macrobead
nonetheless
entrap
macrobead
freefloat
within
tissu
caviti
macrobead
three
implant
dog
also
found
lodg
lobe
liver
evid
broken
macrobead
agaros
macrobead
fragment
observ
embed
lobe
liver
broken
macrobead
observ
two
implant
dog
diffus
fibrot
plaqu
mesotheli
hyperplasia
common
find
seros
surfac
abdomin
wall
abdomin
tissu
prolif
lesion
limit
seros
surfac
appear
extend
organ
parenchyma
cell
section
macroscop
view
mesenteri
implant
control
dog
nearli
ident
figur
demonstr
biocompat
agaros
macrobead
variou
lobe
liver
implant
dog
present
occasion
indent
due
presenc
macrobead
surgic
procedur
time
second
macrobead
implant
sham
surgeri
control
dog
biopsi
tonsil
mesenter
lymph
node
white
blood
cell
collect
studi
anim
assess
perv
necropsi
nine
tissu
bone
marrow
cn
brain
mesenter
lymph
node
small
intestin
heart
kidney
liver
lung
pbmc
islet
macrobead
collect
screen
pcr
presenc
differ
virus
tissu
neg
presenc
pcmv
plhv
perv
semcv
perv
specif
sequenc
detect
islet
macrobead
sampl
sampl
control
implant
dog
low
level
amplif
signal
pcv
found
number
differ
tissu
suggest
crossreact
canin
sequenc
result
studi
demonstr
safeti
transplant
agaroseagaros
porcin
islet
macrobead
fulli
discord
larg
anim
model
treatment
insulin
depend
diabet
importantli
specif
immunosuppress
therapi
administ
although
pravastatin
given
mild
antiinflammatori
properti
three
dog
receiv
porcin
islet
macrobead
insulinfre
approxim
week
follow
first
implant
procedur
preimplant
insulin
requir
reach
follow
week
three
week
implant
anim
full
insulin
requir
remark
implant
dog
reach
preinsulin
requir
follow
second
implant
significantli
longer
period
time
fact
one
anim
still
reach
preimplant
insulin
requir
necropsi
day
follow
implant
signific
issu
xenotransplant
procedur
possibl
xenozoonosi
case
porcin
islet
porcin
endogen
retroviru
perv
encod
throughout
porcin
genom
unlik
remov
viru
gener
consider
attent
xenotransplant
commun
regulatori
author
see
review
denner
tonj
although
perv
shown
infect
human
cell
vitro
evid
transmiss
human
includ
farmer
veterinarian
abattoir
worker
expos
daili
numer
porcin
secret
excret
blood
tissu
year
use
porcin
insulin
clinic
also
reveal
transmiss
perv
preclin
studi
nonhuman
primat
also
detect
evid
perv
transmiss
even
high
dose
immunosuppress
high
titer
perv
also
assur
neg
human
clinic
find
perv
transmiss
date
includ
burn
patient
treat
porcin
skin
patient
hemophilia
treat
porcin
factor
viii
patient
receiv
extracorpor
porcin
hepatocyt
therapi
well
two
clinic
trial
porcin
islet
follow
implant
nonetheless
accident
transmiss
anim
virus
perv
particular
mandat
care
thought
strategi
manag
risk
abil
islet
macrobead
surviv
extend
cultur
period
least
one
year
provid
ampl
opportun
determin
insulin
product
batch
macrobead
also
screen
macrobead
evid
microbiolog
viral
pathogen
recent
demonstr
prolifer
macrobead
encapsul
porcin
insulinproduc
cell
first
week
cultur
time
insulin
product
increas
start
level
gradual
stabil
allow
determin
precis
insulinproduc
capac
encapsul
islet
subsequ
implant
patienttailor
dose
macrobead
meet
individu
insulin
demand
note
islet
macrobead
also
routin
screen
numer
pathogen
prior
implant
studi
anim
tradit
organ
allograft
techniqu
allow
extend
test
time
requir
assur
absenc
xenorel
infecti
diseas
promis
islet
xenotransplant
larg
unreal
restraint
agaroseagaros
islet
macrobead
afford
ampl
time
extens
microbiolog
safeti
test
consid
advanc
techniqu
antemortem
screen
donor
anim
tissu
transplant
test
directli
signific
technolog
advanc
one
potenti
final
make
xenotransplant
realiti
furthermor
addit
patient
safeti
obtain
requir
immunosuppress
macrobead
recipi
similar
find
discuss
found
evid
viral
transmiss
includ
perv
diabet
rat
implant
porcin
islet
macrobead
current
studi
viral
transmiss
also
found
biopsi
mesenter
lymph
node
tissu
tonsil
tissu
peripher
blood
mononuclear
cell
day
implant
immedi
prior
implant
second
dose
macrobead
addit
numer
tissu
collect
necropsi
studi
dog
time
islet
macrobead
implant
dog
expos
porcin
tissu
year
tissu
found
neg
screen
viral
sequenc
although
low
level
amplif
observ
pcv
tissu
dog
includ
nonimpl
control
anim
low
level
amplif
signal
pcv
target
detect
neg
control
macrobead
implant
anim
like
find
due
crossreact
canin
specif
sequenc
neg
find
extens
viral
screen
islet
macrobead
prior
implant
also
support
notion
porcin
islet
macrobead
implant
condit
studi
perform
safe
result
transspeci
viral
transmiss
consist
previou
studi
islet
macrobead
found
extrem
biocompat
necropsi
islet
macrobead
intact
freefloat
periton
caviti
one
anim
evid
broken
macrobead
result
demonstr
abil
islet
macrobead
resist
breakag
vivo
perhap
impress
find
necropsi
mild
degre
inflammatori
reaction
periton
caviti
thought
impair
organ
function
furthermor
data
also
demonstr
capac
abdomen
accommod
larg
number
macrobead
ongo
improv
insulin
secret
capac
islet
macrobead
continu
allow
implant
fewer
macrobead
order
replac
exogen
insulin
final
current
clinic
trial
similarli
size
mous
renal
adenocarcinomacontain
agaros
macrobead
inhibit
variou
cancer
shown
human
abdomen
easili
hous
sever
thousand
macrobead
data
support
feasibl
transplant
agaroseagaros
porcin
islet
macrobead
treatment
strategi
insulin
depend
diabet
mellitu
macrobead
resist
breakag
degrad
nontox
biocompat
abil
incub
porcin
islet
macrobead
extend
period
order
prescreen
islet
numer
pathogen
advanc
safeti
profil
therapi
critic
evid
viral
transmiss
observ
longterm
implant
diabet
studi
anim
project
receiv
substanti
financi
support
metromedia
bioscienc
llc
mmb
agreement
provid
exclus
licens
right
technolog
mmb
addit
royalti
fee
paid
institut
product
ultim
becom
commerci
success
patent
cover
technolog
own
rogosin
institut
ongo
mainten
fee
patent
paid
rogosin
institut
none
author
receiv
compens
kind
directli
mmb
work
perform
entir
direct
rogosin
institut
manner
consist
scientif
review
polici
procedur
govern
structur
howev
cost
associ
salari
benefit
employe
includ
annual
budget
support
project
provid
mmb
